Is there a murine model that fully recapitulates human NASH? An unbiased bioinformatics approach to rank pre-clinical models based on proximity to human disease

被引:0
|
作者
Vacca, Michele [1 ,2 ]
Kamzolas, Ioannis [1 ,3 ]
Harder, Lea Morch [4 ]
Oakley, Fiona [5 ]
Trautwein, Christian [6 ]
Hatting, Maximilian [6 ]
Ross, Trenton [7 ]
Bernardo, Barbara [8 ]
Oldenburger, Anouk [9 ]
Hjuler, Sara Toftegaard [4 ]
Ksiazek, Iwona [10 ]
Linden, Daniel [11 ,12 ]
Schuppan, Detlef [13 ]
Rodriguez-Cuenca, Sergio [1 ]
Tonini, Maria Manuela [14 ]
Kannt, Aimo [15 ,16 ]
Rodriguez-Castaneda, Tamara [15 ]
Rodrigues, Cecilia M. P. [17 ]
Cockell, Simon [18 ]
Govaere, Olivier [19 ]
Daly, Ann K. [19 ]
Allison, Michael [20 ]
De Lichtenberg, Kristian Honnens [4 ]
Kim, Yong Ook [13 ]
Lindblom, Anna [11 ]
Oldham, Stephanie [21 ]
Andreasson, Anne-Christine [11 ]
Schlerman, Franklin [22 ]
Marioneaux, Jonathon [23 ]
Sanyal, Arun [24 ]
Afonso, Marta B. [17 ]
Rinaldi, Anthony [7 ]
Amano, Yuichiro [25 ]
Paradis, Valerie [26 ]
Burt, Alastair [19 ]
Susan, Davies [27 ,30 ]
Driessen, Ann [28 ]
Yashiro, Hiroaki [29 ]
Brosnan, M. Julia
Yunis, Carla
Bedossa, Pierre [31 ]
Tiniakos, Dina [32 ,33 ]
Anstee, Quentin [32 ,34 ]
Petsalaki, Evangelia [3 ]
Davidsen, Peter [4 ]
Perfield, Jim [35 ]
Vidal-Puig, Antonio [1 ]
机构
[1] Univ Cambridge, WT MRC Inst Metab Sci, Cambridge, England
[2] Univ Bari Aldo Moro, Interdisciplinary Dept Med, Bari, Italy
[3] European Mol Biol Lab European Bioinformat Inst E, Wellcome Genome Campus, Cambridge, England
[4] Novo Nordisk Res & Early Dev, Novo Nordisk AS, Copenhagen, Denmark
[5] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Fibrosis Res Grp, Newcastle Upon Tyne, Tyne & Wear, England
[6] Aachen Univ Hosp, Dept Med 3, Aachen, Germany
[7] PfizerWorldwide Res & Dev, Internal Med Res Unit, Pfizer IMRU, Cambridge, MA USA
[8] PfizerWorldwide Res & Dev, Pfizer Internal Med, 558 Eastern Point Rd, Groton, CT 06340 USA
[9] Boehringer Ingelheim Pharma GmbH & Co KG, CardioMetabol Dis Res, Biberach ad Riss, Biberach, Germany
[10] Novartis Pharma AG, Novartis Inst BioMed Res, CH-4056 Basel, Switzerland
[11] AstraZeneca, BioPharmaceut RandD, Cardiovasc Renal & Metab CVRM, AstraZeneca Biosci Metab Res & Early Dev, Gothenburg, Sweden
[12] Univ Gothenburg, Sahlgrenska Acad, Dept Neuroscience & Physiol, Div Endocrinol, Gothenburg, Sweden
[13] Johannes Gutenberg Univ Med Ctr, Inst Translat Immunol & Res Ctr Immunother, Mainz, Germany
[14] Luxembourg Inst Hlth Translat Med Operat Hub, Integrated Biobank Luxembourg IBBL, Luxembourg, Luxembourg
[15] Ind Hoechst, SanofiAventis Deutschland GmbH, RandD Diabet, D-65926 Frankfurt, Germany
[16] Fraunhofer Inst Translat Med & Pharmacol ITMP, Theodor Stern Kai 7, D-60956 Frankfurt, Germany
[17] Univ Lisbon, Fac Pharm, Univ Lisbon Res Inst Med, Lisbon, Portugal
[18] Newcastle Univ, Fac Med Sci, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England
[19] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
[20] Cambridge Univ Hosp NHS Fdn Trust, Liver Unit, Cambridge NIHR Biomed Res Ctr, Cambridge, England
[21] AstraZeneca, Biosci Metab, Res & Early Dev Cardiovasc, Renal & Metab CVRM, Gaithersburg, MD USA
[22] Pfizer Worldwide Res & Dev, Pfizer Inflammat & Immunol Res Unit, Cambridge, MA USA
[23] Sanyal Biotechnol LLC, Norfolk, VA USA
[24] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA
[25] Takeda Pharmaceut Co Ltd, Takeda Pharmaceut Int AG, Fujisawa, Kanagawa, Japan
[26] Univ Paris Diderot, Dept Imaging & Pathol, Hop Beaujon, Paris, France
[27] Cambridge Univ Hosp NHS Fdn Trust, Dept Cellular Pathol, Cambridge, England
[28] Univ Antwerp, Dept Pathol, Antwerp, Belgium
[29] Takeda Pharmaceut Co Ltd, Takeda Pharmaceut Int AG, Cambridge, MA USA
[30] Newcastle Univ, LiverPat, Paris, France
[31] Newcastle Univ, Translat & Clin Res Inst, Newcastle, NSW, France
[32] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
[33] Natl & Kapodistrian Univ Athens, Aretaie Hosp, Sch Med, Athens, Greece
[34] Newcastle Univ, Newcastle Tyne Hosp NHS Trust, Newcastle NIHR Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England
[35] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
基金
欧盟地平线“2020”;
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
GS009
引用
收藏
页码:S7 / S8
页数:2
相关论文
共 38 条
  • [31] Development of ZFN-based pre-clinical in vitro cell model in human embryonic stem cells for Wiskott-Aldrich syndrome
    Toscano, Miguel
    Munoz, Pilar
    Anderson, Per
    Benabdellah, Karim
    Cobo, Marien
    Gregory, Philip
    Holmes, Michael
    HUMAN GENE THERAPY, 2012, 23 (10) : A79 - A79
  • [32] Development of ZFN-based pre-clinical in vitro cell model in human embryonic stem cells for Wiskott-Aldrich syndrome
    Munoz, Pilar
    Toscano, Miguel G.
    Anderson, Per
    Benabdellah, Karim
    Cobo, Marien
    Holmes, Michael
    Martin, Francisco
    HUMAN GENE THERAPY, 2013, 24 (05) : A21 - A21
  • [33] Development of ZFN-based pre-clinical in vitro cell model in human embryonic stem cells for Wiskott-Aldrich syndrome
    Munoz Fernandez, P.
    Garcia Toscano, M.
    Cobo Pulido, M.
    Sanchez Gilabert, A.
    Benabdellah, K.
    Gutierrez Guerrero, A.
    Anderson, P.
    Holmes, M.
    Gregory, P. D.
    Martin Molina, F.
    HUMAN GENE THERAPY, 2013, 24 (12) : A82 - A82
  • [34] Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease
    van der Spoel, Tycho I. G.
    Sanne J. Jansen of Lorkeers
    Agostoni, Pierfrancesco
    van Belle, Eric
    Gyoengyoesi, Mariann
    Sluijter, Joost P. G.
    Cramer, Maarten J.
    Doevendans, Pieter A.
    Chamuleau, Steven A. J.
    CARDIOVASCULAR RESEARCH, 2011, 91 (04) : 649 - 658
  • [35] Improvement of Pre-Clinical Non-Human Primate Model for Pluripotent Stem Cell Based Therapies by Introducing Marker Genes in Safe Harbor Locus
    Yada, Ravi Chandra
    Hong, So Gun
    Zou, Jizhong
    Choi, Kyujoo
    Carpentier, Arnaud
    Liang, T. Jake
    Merling, Randall
    Sweeney, Colin
    Malech, Harry
    Jung, Moonjung
    Corat, Marcus
    Lin, Youngshun
    Tunc, Ilker
    Wang, Xujing
    Palisoc, Maryknoll
    Pittaluga, Stefania
    Winkler, Thomas
    Dunbar, Cynthia
    MOLECULAR THERAPY, 2016, 24 : S210 - S211
  • [36] A Fully-Human Armored BCMA CAR Boosts Function of CD4+ CAR-T Cells and Resists TGF-β Suppression in Pre-Clinical Models of Multiple Myeloma
    Alabanza, Leah
    Vu, Bang
    Wu, Darong
    Zhu, Zhongyu
    Dropulic, Boro
    Schneider, Dina
    BLOOD, 2020, 136
  • [37] Mobilized Mouse and Human Peripheral Blood Containing Elevated Numbers of Donor Treg Cells Ameliorates Pre-Clinical GvHD and GVL Is Maintained in an MHC-Matched Allogeneic Murine Model
    Barreras, Henry, Jr.
    Copsel, Sabrina N.
    Ding, Ying
    Cash, Charles J.
    Bader, Cameron S.
    Benjamin, Cara L.
    Komanduri, Krishna V.
    Malek, Thomas R.
    Levy, Robert B.
    BLOOD, 2021, 138
  • [38] HUMAN MICROBIOTA-REACTIVE DP8. REGULATORY T CELLS EXPRESSING CD73 ARE LACKING IN ACUTE GVHD PATIENTS AND PREVENT DISEASE DEVELOPMENT IN A PRE-CLINICAL HUMANIZED MOUSE MODEL
    Godefroy, Emmanuelle
    Chevallier, Patrice
    Haspot, Fabienne
    Vignes, Caroline
    Daguin, Veronique
    Lambot, Sylvia
    Guillaume, Thierry
    Verdon, Margaux
    Peterlin, Pierre
    Garnier, Alice
    Mougon, Maxence
    Le Bourgeois, Amandine
    Jullien, Maxime
    Jotereau, Francine
    Altare, Frederic
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 67 - 68